| A wearable electrochemical biosensor for the monitoring of metabolites and nutrients M Wang, Y Yang, J Min, Y Song, J Tu, D Mukasa, C Ye, C Xu, N Heflin, ... Nature Biomedical Engineering 6 (11), 1225-1235, 2022 | 488 | 2022 |
| Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study TS Bekaii-Saab, FS Ou, DH Ahn, PM Boland, KK Ciombor, EN Heying, ... The lancet oncology 20 (8), 1070-1082, 2019 | 280 | 2019 |
| Perception of chemotherapy side effects cancer versus noncancer patients C Lindley, JS McCune, TE Thomason, D Lauder, A Sauls, S Adkins, ... Cancer practice 7 (2), 59-65, 1999 | 277 | 1999 |
| Why has model‐informed precision dosing not yet become common clinical reality? Lessons from the past and a roadmap for the future AS Darwich, K Ogungbenro, AA Vinks, JR Powell, JL Reny, N Marsousi, ... Clinical Pharmacology & Therapeutics 101 (5), 646-656, 2017 | 239 | 2017 |
| Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation M Mielcarek, T Furlong, PV O’Donnell, BE Storer, JS McCune, R Storb, ... Blood, The Journal of the American Society of Hematology 127 (11), 1502-1508, 2016 | 237 | 2016 |
| Plasma concentration monitoring of busulfan: does it improve clinical outcome? JS McCune, JP Gibbs, JT Slattery Clinical pharmacokinetics 39, 155-165, 2000 | 196 | 2000 |
| In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasone JS McCune, RL Hawke, EL LeCluyse, HH Gillenwater, G Hamilton, ... Clinical Pharmacology & Therapeutics 68 (4), 356-366, 2000 | 193 | 2000 |
| Development and validation of a novel acute myeloid leukemia–composite model to estimate risks of mortality ML Sorror, BE Storer, AT Fathi, AT Gerds, BC Medeiros, P Shami, ... JAMA oncology 3 (12), 1675-1682, 2017 | 177 | 2017 |
| Potential of chemotherapy–herb interactions in adult cancer patients JS McCune, AJ Hatfield, AAR Blackburn, PO Leith, RB Livingston, ... Supportive care in cancer 12, 454-462, 2004 | 176 | 2004 |
| Addition of vincristine and irinotecan to vincristine, dactinomycin, and cyclophosphamide does not improve outcome for intermediate-risk rhabdomyosarcoma: a report from the … DS Hawkins, YY Chi, JR Anderson, J Tian, CAS Arndt, L Bomgaars, ... Journal of Clinical Oncology 36 (27), 2770-2777, 2018 | 167 | 2018 |
| Busulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and Bayesian dose personalization JS McCune, MJ Bemer, JS Barrett, K Scott Baker, AS Gamis, NHG Holford Clinical Cancer Research 20 (3), 754-763, 2014 | 163 | 2014 |
| Personalizing busulfan-based conditioning: considerations from the american society for blood and marrow transplantation practice guidelines committee J Palmer, JS McCune, MA Perales, D Marks, J Bubalo, M Mohty, ... Biology of Blood and Marrow Transplantation 22 (11), 1915-1925, 2016 | 158 | 2016 |
| A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic … RA Nash, L Johnston, P Parker, JS McCune, B Storer, JT Slattery, ... Biology of Blood and Marrow Transplantation 11 (7), 495-505, 2005 | 144 | 2005 |
| A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer MT Schweizer, K Haugk, JS McKiernan, R Gulati, HH Cheng, JL Maes, ... PloS one 13 (6), e0198389, 2018 | 138 | 2018 |
| Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation JS McCune, T Gooley, JP Gibbs, JE Sanders, EW Petersdorf, ... Bone marrow transplantation 30 (3), 167-173, 2002 | 138 | 2002 |
| Cancer pain survey: patient-centered issues in control TE Thomason, JS McCune, SA Bernard, EP Winer, S Tremont, ... Journal of pain and symptom management 15 (5), 275-284, 1998 | 136 | 1998 |
| Busulfan in hematopoietic stem cell transplant setting JS McCune, LA Holmberg Expert opinion on drug metabolism & toxicology 5 (8), 957-969, 2009 | 126 | 2009 |
| Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates BC Beard, GD Trobridge, C Ironside, JS McCune, JE Adair, HP Kiem The Journal of clinical investigation 120 (7), 2345-2354, 2010 | 124 | 2010 |
| The effect of cyclophosphamide with and without dexamethasone on cytochrome P450 3A4 and 2B6 in human hepatocytes C Lindley, G Hamilton, JS McCune, S Faucette, SS Shord, RL Hawke, ... Drug metabolism and disposition 30 (7), 814-822, 2002 | 119 | 2002 |
| Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen HJ Deeg, BE Storer, M Boeckh, PJ Martin, JS McCune, D Myerson, ... Biology of Blood and Marrow Transplantation 12 (5), 573-584, 2006 | 110 | 2006 |
Brenda SandmaierFred Hutchinson Cancer Research CenterCorreu electrònic verificat a fredhutch.org
